News

Displaying 1 - 5 of 5

photo of Alexis

Speech by EMCDDA Director, Alexis Goosdeel, on the occasion of the launch of the European Drug Report 2022, 14 June 2022

Good morning, First of all, I would like to express our warm thanks to Commissioner Ylva Johansson for her permanent support and also to Dr Franz Pietsch, the Chair of the EMCDDA...

Drug supply and use bounce back after COVID-19 disruption

The rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2022...

image of part of the european drug report 2021

European drug market proves resilient to COVID-19 disruption

Today, the EU drugs agency (EMCDDA) publishes its European Drug Report 2021: Trends and Developments, the latest annual review of the drug situation in Europe (1). Based on data from 29 countries...

EDR covers

Save the date: European Drug Report 2020 to be released on 22 September

How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production...

Cocaine seizures at record levels in a competitive drug market

Europe is seeing signs of an increase in cocaine availability, with seizures of the drug at record levels. This is according to the European Drug Report 2019: Trends and Developments, released by...